Literature DB >> 24416582

Functional imaging in radiation therapy planning for head and neck cancer.

Luis A Pérez Romasanta1, María José García Velloso2, Antonio López Medina3.   

Abstract

Functional imaging and its application to radiotherapy (RT) is a rapidly expanding field with new modalities and techniques constantly developing and evolving. As technologies improve, it will be important to pay attention to their implementation. This review describes the main achievements in the field of head and neck cancer (HNC) with particular remarks on the unsolved problems.

Entities:  

Keywords:  Functional imaging; Metabolic imaging; PET/CT; Radiotherapy planning

Year:  2013        PMID： 24416582      PMCID： PMC3863200          DOI： 10.1016/j.rpor.2013.10.007

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN： 1507-1367


  67 in total

Review 1.  The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment.

Authors:  D G Norris
Journal:  NMR Biomed       Date:  2001-04       Impact factor: 4.044

2.  Adaptive dose painting by numbers for head-and-neck cancer.

Authors:  Fréderic Duprez; Wilfried De Neve; Werner De Gersem; Marc Coghe; Indira Madani
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-17       Impact factor: 7.038

3.  Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.

Authors:  Mitchell Machtay; Mona Natwa; Jocelyn Andrel; Terry Hyslop; P Rani Anne; Jororsali Lavarino; Charles M Intenzo; William Keane
Journal:  Head Neck       Date:  2009-02       Impact factor: 3.147

4.  Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.

Authors:  Haruo Inokuchi; Takeshi Kodaira; Hiroyuki Tachibana; Tatsuya Nakamura; Natsuo Tomita; Rie Nakahara; Akinori Takada; Nobutaka Mizoguchi; Tsuneo Tamaki; Nobukazu Fuwa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-29       Impact factor: 7.038

5.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Authors:  Heiko Schöder; Diane L Carlson; Dennis H Kraus; Hilda E Stambuk; Mithat Gönen; Yusuf E Erdi; Henry W D Yeung; Andrew G Huvos; Jatin P Shah; Steven M Larson; Richard J Wong
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

6.  Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.

Authors:  James D Murphy; Karen M Chisholm; Megan E Daly; Ellen A Wiegner; Daniel Truong; Andrei Iagaru; Peter G Maxim; Billy W Loo; Edward E Graves; Michael J Kaplan; Christina Kong; Quynh-Thu Le
Journal:  Radiother Oncol       Date:  2011-06-12       Impact factor: 6.280

7.  Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

Authors:  Sungheon Kim; Laurie Loevner; Harry Quon; Eric Sherman; Gregory Weinstein; Alex Kilger; Harish Poptani
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

8.  18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome.

Authors:  Bianca A W Hoeben; Esther G C Troost; Paul N Span; Carla M L van Herpen; Johan Bussink; Wim J G Oyen; Johannes H A M Kaanders
Journal:  J Nucl Med       Date:  2013-01-23       Impact factor: 10.057

9.  PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study.

Authors:  Andrew M Scott; Dishan H Gunawardana; Dylan Bartholomeusz; Jayne E Ramshaw; Peter Lin
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

10.  Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.

Authors:  P Xie; J-B Yue; Z Fu; R Feng; J-M Yu
Journal:  Ann Oncol       Date:  2009-11-13       Impact factor: 32.976
View more
  5 in total

1.  Influence of the type of imaging on the delineation process during the treatment planning.

Authors:  Weronika Jackowiak; Bartosz Bąk; Anna Kowalik; Adam Ryczkowski; Małgorzata Skórska; Małgorzata Paszek-Widzińska
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-18

2.  Locally advanced hypopharyngeal squamous cell carcinoma: single-institution outcomes in a cohort of patients curatively treated either with or without larynx preservation.

Authors:  Isabel Reis; Artur Aguiar; Cristiana Alzamora; Carolina Ferreira; Vera Castro; André Soares; Marisa Lobão
Journal:  Radiol Bras       Date:  2016 Jan-Feb

3.  Comparative treatment planning study on sequential vs. simultaneous integrated boost in head and neck cancer patients: Differences in dose distributions and potential implications for clinical practice.

Authors:  Carmen Stromberger; Pirus Ghadjar; Simone Marnitz; Alexander Henry Thieme; Ulrich Jahn; Jan D Raguse; Evis Karaj-Rossbacher; Arne Böttcher; Basil Jamil; Volker Budach
Journal:  Strahlenther Onkol       Date:  2016-01       Impact factor: 3.621

Review 4.  Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

Authors:  José A González Ferreira; Javier Jaén Olasolo; Ignacio Azinovic; Branislav Jeremic
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-04

5.  Multimodality functional imaging in radiation therapy planning: relationships between dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET.

Authors:  Moisés Mera Iglesias; David Aramburu Núñez; José Luis Del Olmo Claudio; Antonio López Medina; Iago Landesa-Vázquez; Francisco Salvador Gómez; Brandon Driscoll; Catherine Coolens; José L Alba Castro; Victor Muñoz
Journal:  Comput Math Methods Med       Date:  2015-02-19       Impact factor: 2.238
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.